Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause

NCT02013544 is registered in ClinicalTrials.gov with EndoCeutics Inc. as lead sponsor.

NCT NCT02013544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02013544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause
Lead sponsor
EndoCeutics Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2014
Completion date
February 28, 2015
Enrollment
558 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

vaginal atrophy